Dapagliflozin 5Mg Tab

DRUG2 trials

Sponsors

Damanhour University, Sherihan AboElyazed Mohamed Khalil

Conditions

Diabetes Mellitus, Type 2MAFLD in Prediabetes and Diabetes

Phase 4

Effect of SGLT2 Inhibitor on Metabolic-Dysfunction-Associated Fatty Liver Disease in Patients With Insulin Resistance

Not yet recruitingNCT07891234

Sherihan AboElyazed Mohamed KhalilMAFLD in Prediabetes and Diabetes

Start: 2026-10-01End: 2027-10-01Target: 66Updated: 2026-10-23

Unknown Phase

Dapagliflozin Versus Glimepiride Effect in Patient With Type 2 Diabetes Mellitus

CompletedNCT04240171

Damanhour UniversityDiabetes Mellitus, Type 2

Start: 2020-12-01End: 2022-01-31Updated: 2023-04-18

Related Papers

Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus.

2023-04-182 citations